Literature DB >> 14527053

Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy.

Terri J Menke1, Thomas P Giordano, Linda Rabeneck.   

Abstract

In the highly active antiretroviral therapy (HAART) era, U.S. African-American and Hispanic patients with HIV use HAART less, but emergency and inpatient services more, than white patients. We evaluated whether these patterns existed in the pre-HAART era. Data from prospective cohort studies of 462 male Veterans Affairs patients and 1,309 male patients from the AIDS Costs and Services Utilization Survey were combined. Resource utilization of white, African-American, and Hispanic men was compared. Compared to whites, African Americans were more likely to visit the emergency department and less likely to have mental health, home health, and dental visits; had fewer outpatient and substance abuse treatment visits; and had more inpatient nights. Hispanics were less likely to have mental health and home health visits, and had more inpatient nights. Whites used prescription drugs more than African Americans or Hispanics, but antiretrovirals were equally used. Lower access to HAART for African-American and Hispanic patients is a new phenomenon, not a continuation of pre-HAART patterns, while the undesirable patterns of emergency and outpatient provider resource utilization in the HAART era are a continuation of pre-HAART patterns. Undesirable resource utilization patterns by African-American and Hispanic populations need urgent attention.

Entities:  

Mesh:

Year:  2003        PMID: 14527053      PMCID: PMC2594468     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  31 in total

1.  Access and use of specific dental services in HIV disease.

Authors:  A K Mascarenhas; S R Smith
Journal:  J Public Health Dent       Date:  2000       Impact factor: 1.821

2.  An investigation of why eligible patients do not receive HAART.

Authors:  L Maisels; J Steinberg; C Tobias
Journal:  AIDS Patient Care STDS       Date:  2001-04       Impact factor: 5.078

3.  Racial differences in attitudes toward protease inhibitors among older HIV-infected men.

Authors:  K Siegel; D Karus; E W Schrimshaw
Journal:  AIDS Care       Date:  2000-08

4.  Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.

Authors:  W E Cunningham; L E Markson; R M Andersen; S H Crystal; J A Fleishman; C Golin; A Gifford; H H Liu; T T Nakazono; S Morton; S A Bozzette; M F Shapiro; N S Wenger
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

5.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

6.  The effect of patients' preferences on racial differences in access to renal transplantation.

Authors:  J Z Ayanian; P D Cleary; J S Weissman; A M Epstein
Journal:  N Engl J Med       Date:  1999-11-25       Impact factor: 91.245

7.  Clinical and socioeconomic determinants of health care use among HIV-infected patients in the Department of Veterans Affairs.

Authors:  T J Menke; L Rabeneck; P M Hartigan; M S Simberkoff; N P Wray
Journal:  Inquiry       Date:  2000       Impact factor: 1.730

8.  Use of dental care by HIV-infected medical patients.

Authors:  I D Coulter; M Marcus; J R Freed; C Der-Martirosian; W E Cunningham; R M Andersen; W R Maas; I Garcia; D A Schneider; B Genovese; M F Shapiro; S A Bozzette
Journal:  J Dent Res       Date:  2000-06       Impact factor: 6.116

Review 9.  Quality Enhancement Research Initiative for human immunodeficiency virus/acquired immunodeficiency syndrome: framework and plan. HIV-QUERI Executive Committee.

Authors:  S A Bozzette; B Phillips; S Asch; A L Gifford; L Lenert; T Menke; E Ortiz; D Owens; L Deyton
Journal:  Med Care       Date:  2000-06       Impact factor: 2.983

10.  Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Authors:  G M Lucas; R E Chaisson; R D Moore
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

View more
  6 in total

1.  Is there a race-based disparity in the survival of veterans with HIV?

Authors:  Thomas P Giordano; Robert O Morgan; Jennifer R Kramer; Christine Hartman; Peter Richardson; Clinton A White; Maria E Suarez-Almazor; Hashem B El-Serag
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

2.  If I didn't have HIV, I'd be dead now: illness narratives of drug users living with HIV/AIDS.

Authors:  Katie E Mosack; Maryann Abbott; Merrill Singer; Margaret R Weeks; Lucy Rohena
Journal:  Qual Health Res       Date:  2005-05

3.  Disparate use of minimally invasive surgery in benign surgical conditions.

Authors:  Rocco Ricciardi; Harry P Selker; Nancy N Baxter; Peter W Marcello; Patricia L Roberts; Beth A Virnig
Journal:  Surg Endosc       Date:  2008-07-02       Impact factor: 4.584

4.  Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.

Authors:  Diana C Lemly; Bryan E Shepherd; Todd Hulgan; Peter Rebeiro; Samuel Stinnette; Robert B Blackwell; Sally Bebawy; Asghar Kheshti; Timothy R Sterling; Stephen P Raffanti
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

5.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

6.  Emergency department utilization by HIV-positive adults in the HAART era.

Authors:  Arvind Venkat; Brian Shippert; Douglas Hanneman; Chadd Nesbit; David M Piontkowsky; Sunil Bhat; Morgen Kelly
Journal:  Int J Emerg Med       Date:  2008-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.